Outcome of Board Meeting held on February 14, 2026 and Submission of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31, 2025 as per SEBI (Listing ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.3 pts less than Nifty Microcap 250 and 2.3 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
ZR2 Bioenergy reported Q3 FY26 standalone profit after tax of Rs. 23.02 lakhs, swinging from a loss of Rs. 26.35 lakhs in Q3 FY25. Other income of Rs. 41.63 lakhs made up the entire quarter's income, with revenue from operations remaining nil. Total expenses fell to Rs. 21.72 lakhs from Rs. 29.55 lakhs a year ago. Nine-month FY26 PAT stood at Rs. 80.96 lakhs versus a loss of Rs. 2.30 lakhs in the same period last year. Consolidated numbers were broadly similar, including the new wholly owned subsidiary ZR2 Solar Pvt Ltd incorporated in October 2024. Statutory auditors Bagaria & Co LLP issued an unqualified limited review opinion on both sets of results.
The turnaround from loss to profit is positive on paper, but results are driven entirely by other income rather than core operating revenue, suggesting the business is still in transition after the change of control to ZR2 Group Holdings in late 2024. Investors should watch for actual revenue from operations picking up in coming quarters to confirm a sustainable recovery.